Bristol-Myers misses 3Q profit forecasts
On a per-share basis, the New York-based company said it had net income of 51 cents. Earnings, adjusted for non-recurring costs, were 75 cents per share.
from Biotech News
On a per-share basis, the New York-based company said it had net income of 51 cents. Earnings, adjusted for non-recurring costs, were 75 cents per share.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments